Turk Kardiyol Dern Ars. 2017; 45(2): 167-171 | DOI: 10.5543/tkda.2016.21866
Management of immediate partial bioresorbable vascular scaffold stent thrombosis
Ziad Said Dahdouh1, Bahaa M Fadel1, Hani Al Sergani1, Jehad Al Buraiki1, Gilles Grollier21Heart Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2Department of Interventional Cardiology, University Hospital of Caen, Caen, France
Bioresorbable vascular scaffold (BVS) stents have been proposed recently as an elegant technique for treatment of coronary artery disease. However, perspective that these “dissolvable” stents will replace conventional metallic stents in broad spectrum of clinical conditions and patient categories in the near future has been moderated by non-negligible incidence of stent thrombosis (ST). Mechanical factors, such as strut thickness and malapposition have been implicated in increased risk of BVS ST. Presently described is case of immediate partial BVS ST in a young male related to technical procedural problem, rather than mechanical problem. Glycoprotein IIb/IIIa inhibitors associated with anticoagulation resulted in complete resolution of thrombus and facilitated successful patient outcome.
Keywords: Bioresorbable vascular scaffold, glycoprotein IIb/IIIa inhibitors, in-scaffold thrombosis, percutaneous coronary intervention.
Corresponding Author: Ziad Said Dahdouh, Saudi Arabia
Manuscript Language: English